Lyonbiopole Diseases Center opened its doors on April 1st, 2009 at the Domilyon building in Lyon-Gerland (7th district). It is already full, hosting six research teams: Inserm U851, Inserm U851/Finovi, the Mérieux Institute, the PLATINE project (Innate-Pharma, Transgene, ImmunID, Inserm and the Léon Bérard Cancer Research Center), PX’Therapeutics and Transgene.
This platform, the only one of its kind in Europe, features 1,920 sq. m. of Biosafety Level 2 and 3 laboratories and shared facilities.
They speak about...
« Lyon is a leading region for biotechnology in the health sector. Genzyme naturally found it an ideal location to set up its new bioproduction site dedicated to transplants. Being located nearby other players in the health sector is a real advantage for us, a true source of motivation. This enables us to communicate with and meet each other and helps us come up with new ideas. We set up our facilities in places where our ambition to create value in our business sector can be accomplished while remaining faithful to our mission of innovating for patients who are awaiting treatment. »
Frédéric Turner
Genzyme - Director